Carlos Alcaraz will not play at his home Masters 1000 for the second year running. The 22-year-old Spaniard withdrew from the Mutua Madrid Open on Sunday with a wrist and forearm injury first felt at the Barcelona Open, a setback that has now cast doubt over both the Italian Open in Rome and his participation at the French Open at the end of May. "Madrid is out, Rome seems almost impossible to me," tournament director Feliciano LĂłpez said, speaking from personal experience of a comparable injury.
The chronology matters. Alcaraz arrived in Barcelona already carrying the mileage of a Monte Carlo campaign that had asked a lot of his body. In his opening match against Finlandâs Otto Virtanen, he called the physio during a changeover, stayed on court to close out a 6-4, 6-2 win, and then pulled out of the tournament the next day when medical tests returned a picture worse than hoped. That single changeover â and the decision to continue â now sits at the centre of a recovery timeline measured in weeks rather than days.
LĂłpez: "His Wrist Tendon Is a Bit Inflamed"
Feliciano LĂłpez, a former top-15 player and now Madridâs tournament director, has been unusually specific in his public remarks. He has also been candid about the limits of his own information. "Iâve had that injury myself," he told reporters. "Itâs a very common injury in the world of tennis. I think his wrist tendon is a bit inflamed â I donât know what his injury is like, the extent of it." He also disclosed that he had been sidelined for roughly two months with what he believed to be a similar issue.
LĂłpezâs own timeline, if it maps onto Alcarazâs, is where the concerns about Rome and Roland Garros come from. The Italian Open begins in early May. The French Open starts on May 25. Two months from the Barcelona flare-up would put Alcarazâs return right at the edge of the Paris draw â and edge-of-the-draw fitness for a Grand Slam, on clay, is not a winning formula.
"Maybe This Week Is the One Where I Should Rest"
Alcaraz, in his own statement, has been philosophical but realistic. "Madrid is home, one of the most special places on my calendar, and thatâs why it hurts so much not to be able to play here for the second year in a row," he said. He also acknowledged, with an unusual directness for a player his age, that he had probably pushed too far. "Maybe this week is the one where I should rest."
That admission is notable for two reasons. First, because players rarely admit mid-season that their schedule was too aggressive. Second, because Alcaraz has historically been one of the most competitive and intense players on tour, someone for whom resting is counter-intuitive. The willingness to say it publicly suggests the medical advice has been firm.
The Roland Garros Equation
Paris is the tournament that now hangs over the rest of the clay swing. Alcaraz has framed his own participation in characteristically sober terms: "Pushing now could harm me in the future." Coaches and medical teams will be weighing a set of competing priorities that are rarely aligned â ranking points, tour narrative, Grand Slam history, long-term wrist health, and the ability to play on the surface where he feels most at home.
Wrists are not ankles. A tendon that has been compromised does not always respond to a two-week rest window. If Alcaraz returns to competition before he is fully recovered, he is likely to re-aggravate the injury within the first long rally of a first match. If he rests through Rome and returns at Roland Garros, he will arrive under-prepared on the most demanding surface for wrist work in tennis. Neither option is clean.
What the Field Inherits
In Alcarazâs absence, Madrid becomes Jannik Sinnerâs tournament to dominate unless one of the in-form clay specialists rises to meet him. Novak Djokovic is also out of Madrid, further thinning the top of the draw. The Italian, working through his own return to form, is in a position to pick up ranking points and match confidence at a stage of the season when every set on clay counts.
For the tournament, the absence of its defending home interest is a commercial blow. For the broader ATP season, it narrows the field of contenders for the clay Slam and, in doing so, redraws the tactical math for the middle tier of players who now have a cleaner path through the middle rounds of a Masters 1000.
What Comes Next
Alcarazâs team has not given a specific return date. The likely sequence is a conservative rehabilitation window, a medical review in the back half of April, and a decision on Rome in early May. A decision on Paris would follow shortly afterwards.
In the best-case version of the next month, Alcaraz recovers, tests the wrist in practice sets, and arrives in Paris as the second favourite. In the worst case, he misses the French Open entirely. The distance between those two outcomes is not a matter of will. It is a matter of tendon.
%2Forigin-imgresizer.tntsports.io%2F2026%2F04%2F12%2Fimage-09397dbe-e2d0-4363-89b4-23ea6cb6c9a9-85-2560-1440.jpeg&w=3840&q=75)





